1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Rare Neurological Disease Treatment Market – By Indication

1.3.2        Europe Rare Neurological Disease Treatment Market – By Drug Type

1.3.3        Europe Rare Neurological Disease Treatment Market – By Distribution Channel

1.3.4        Europe Rare Neurological Disease Treatment Market – By Mode of Administration

1.3.5        Europe Rare Neurological Disease Treatment Market – By Country

2.           Europe Rare Neurological Disease Treatment Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Rare Neurological Disease Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Rare Neurological Disease Treatment Market - Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Rare Neurological Disease Treatment Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Prevalence of Rare Neurological Diseases

5.1.2        Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases

5.2         Key Restraints

5.2.1        High Treatment Cost for Rare Neurological Diseases

5.3         Key Market Opportunities

5.3.1        Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure

5.4         Future Trend

5.4.1        Artificial Intelligence for the Treatment of Rare Neurological Diseases

5.5         Impact Analysis

6.           Rare Neurological Disease Treatment Market – Europe Analysis

6.1         Europe Rare Neurological Disease Treatment Market Revenue Forecasts and Analysis

7.           Europe Rare Neurological Disease Treatment Market Analysis And Forecasts To 2027 – By Indication

7.1         Overview

7.2         Europe Rare Neurological Disease Treatment Market, By Indication 2019 & 2027 (%)

7.2.1        Europe Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Indication (US$ Mn)

7.3         Narcolepsy

7.3.1        Overview

7.3.2        Europe Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Amyotrophic Lateral Sclerosis

7.4.1        Overview

7.4.2        Europe Amyotrophic Lateral Sclerosis Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Alzheimer’s Disease

7.5.1        Overview

7.5.2        Europe Alzheimer’s Disease Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Multiple Sclerosis

7.6.1        Overview

7.6.2        Europe Multiple Sclerosis Market Revenue and Forecast to 2027 (US$ Mn)

7.7         Spinal Muscular Atrophy (SMA)

7.7.1        Overview

7.7.2        Europe Spinal Muscular Atrophy Market Revenue and Forecast to 2027 (US$ Mn)

7.8         Duchenne Muscular Dystrophy

7.8.1        Overview

7.8.2        Europe Duchenne Muscular Dystrophy Market Revenue and Forecast to 2027 (US$ Mn)

7.9         Other Indications

7.9.1        Overview

7.9.2        Europe Other Indications Market Revenue and Forecast to 2027 (US$ Mn)

8.           Europe Rare Neurological Disease Treatment Market Analysis– By Drug Type

8.1         Overview

8.2         Europe Rare Neurological Disease Treatment Market, By Drug Type 2019-2027 (%)

8.2.1        Europe Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Drug Type (US$ Mn)

8.3         Organic Compounds

8.3.1        Overview

8.3.2        Europe Organic Compounds Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Biologics

8.4.1        Overview

8.4.2        Europe Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Europe Rare Neurological Disease Treatment Market Analysis– By Distribution Channel

9.1         Overview

9.2         Europe Rare Neurological Disease Treatment Market, By Distribution Channel 2019 & 2027 (%)

9.2.1        Europe Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

9.3         Online Pharmacies

9.3.1        Overview

9.3.2        Europe Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Retail Pharmacies

9.5.1        Overview

9.5.2        Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Europe Rare Neurological Disease Treatment Market Analysis– By Mode of Administration

10.1      Overview

10.2      Europe Rare Neurological Disease Treatment Market, By Mode of Administration 2019 & 2027 (%)

10.2.1     Europe Rare Neurological Disease Treatment Market Revenue and Forecasts to 2027, By Mode of Administration (US$ Mn)

10.3      Oral

10.3.1     Overview

10.3.2     Europe Oral Market Revenue and Forecast to 2027 (US$ Mn)

10.4      Injectable

10.4.1     Overview

10.4.2     Europe Injectable Market Revenue and Forecasts to 2027 (US$ Mn)

11.        Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      Europe Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027

11.1.1     Overview

11.1.2     Europe: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)

11.1.3     Europe: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.4     Europe: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.5     Europe: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.6     Europe: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.7     Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

11.1.8     Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       Germany: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.8.3       Germany: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.8.4       Germany: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.8.5       Germany: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.9     United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       United Kingdom: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.9.3       United Kingdom: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.9.4       United Kingdom: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.9.5       United Kingdom: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.10  France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    France: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.10.3    France: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.10.4    France: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.10.5    France: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.11  Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    Spain: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.11.3    Spain: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.11.4    Spain: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.11.5    Spain: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.12  Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.2    Italy: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

11.1.12.3    Italy: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

11.1.12.4    Italy: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

11.1.12.5    Italy: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

12.        Impact Of COVID-19 Pandemic On Europe Rare Neurological Diseases Treatment Market

12.1      Europe: Impact assessment of COVID-19 Pandemic

13.        Europe Rare Neurological Disease Treatment Market Industry Landscape

13.1      Overview

13.2      Organic Growth Strategies

13.2.1     Overview

14.        Company Profiles

14.1      Allergan Plc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bayer AG

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      GlaxoSmithKline plc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Novartis AG

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Sanofi

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Indication (US$ Mn)

Table 2.             Europe Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Drug Type (US$ Mn)

Table 3.             Europe Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 4.             Europe Rare Neurological Disease Treatment Market Revenue and Forecasts To 2027, By Mode of Administration (US$ Mn)

Table 5.             Europe Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 6.             Europe Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             Europe Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8.             Europe Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             Germany Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 10.          Germany Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Germany Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 12.          Germany Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          United Kingdom Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 14.          United Kingdom Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          United Kingdom Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027  (USD Million)

Table 16.          United Kingdom Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          France Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027  (USD Million)

Table 18.          France Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          France Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 20.          France Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Spain Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 22.          Spain Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          Spain Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 24.          Spain Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          Italy Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 26.          Italy Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          Italy Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

Table 28.          Italy Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 29.          Recent Inorganic Growth Strategies In The Rare Neurological Disease Treatment Market

Table 30.          Recent Organic Growth Strategies In The Rare Neurological Disease Treatment Market

Table 31.          Glossary of Terms, Rare Neurological Disease Treatment Market

LIST OF FIGURES

Figure 1.           Rare Neurological Disease Treatment Market Segmentation

Figure 2.           Europe Rare Neurological Disease Treatment Market Overview

Figure 3.           Alzheimer’s Disease Segment Held Largest Share of Indication Segment in Rare Neurological Disease Treatment Market

Figure 4.           Germany Is Expected To Show Remarkable Growth During The Forecast Period

Figure 5.           Europe Rare Neurological Disease Treatment Market- Leading Country Markets (US$ Mn)

Figure 6.           Rare Neurological Disease Treatment Market, Industry Landscape

Figure 7.           Rare Neurological Disease Treatment Market - Europe PEST Analysis

Figure 8.           Rare Neurological Disease Treatment Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Rare Neurological Disease Treatment Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Europe Rare neurological disease treatment Market, By Indication 2019 & 2027 (%)

Figure 11.        Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Europe Amyotrophic Lateral Sclerosis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Europe Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Europe Multiple Sclerosis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Europe Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Europe Duchenne Muscular Dystrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Europe Other Indications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Europe Rare Neurological Disease Treatment Market, by Drug Type 2019 & 2027 (%)

Figure 19.        Europe Organic Compounds Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Europe Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Europe Rare Neurological Disease Treatment Market, By Distribution Channel 2019 & 2027 (%)

Figure 22.        Europe Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Europe Rare Neurological Disease Treatment Market, By Mode of Administration 2019 & 2027 (%)

Figure 26.        Europe Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Europe Injectable Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Europe: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 29.        Europe Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

Figure 30.        Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

Figure 31.        Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic In European Country Markets